Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Design & Build
GE Healthcare to open biotechnology manufacturing centre in UK
Located at the Stevenage Bioscience Catalyst, the facility includes 280sqm of cleanroom space
Research & Development
Consortium of UK Universities and global pharma companies launch £40m innovation fund
Apollo Therapeutics Fund will support translation of academic science into medicines for a broad range of diseases
Research & Development
Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board
Will guide open innovation campus in a phase of rapid development
Research & Development
Stevenage Bioscience Catalyst to fund six projects to fight neurodegenerative disease
Diverse players collaborate on first step in plan to tackle disorder through open innovation
Research & Development
New £55m cell therapy manufacturing centre to be built in Stevenage, UK
Will open in 2017 and create up to 150 jobs
Research & Development
GE Healthcare Life Sciences links up with Stevenage Bioscience Catalyst (SBC)
Joins neurodegenerative disease challenge and expands commitment to open innovation in healthcare
Research & Development
Stevenage Bioscience Catalyst gains £3m in funding
One tenant has also secured further funding, while another has extended its research collaborations
Subscribe now